中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2015年
24期
53-55
,共3页
中药制剂%脑梗死%治疗效果%规范化
中藥製劑%腦梗死%治療效果%規範化
중약제제%뇌경사%치료효과%규범화
Traditional Chinese medicine injection%Cerebral infarction%Curative effect%Standardization
目的：观察中药制剂治疗脑梗死患者的临床疗效，并研究其治疗的规范化。方法：对我院2012年3月1日—2014年3月31日所治疗的46例脑梗死患者，随机分为对照组和观察组各23例，观察组患者采用中药注射剂治疗，对照组的患者采用西药针剂，疗程均为3周，3个月后对其进行治疗回访，进而分析对比两组患者的治疗效果。结果：治疗后两组患者的临床表现均有所改善，与治疗前相比，存在明显的差异；观察组的治疗效果显著优于对照组，P＜0.05为差异显著有统计学意义。结论：采用中药注射剂辅助脑梗死患者的治疗，效果显著，值得推广。
目的：觀察中藥製劑治療腦梗死患者的臨床療效，併研究其治療的規範化。方法：對我院2012年3月1日—2014年3月31日所治療的46例腦梗死患者，隨機分為對照組和觀察組各23例，觀察組患者採用中藥註射劑治療，對照組的患者採用西藥針劑，療程均為3週，3箇月後對其進行治療迴訪，進而分析對比兩組患者的治療效果。結果：治療後兩組患者的臨床錶現均有所改善，與治療前相比，存在明顯的差異；觀察組的治療效果顯著優于對照組，P＜0.05為差異顯著有統計學意義。結論：採用中藥註射劑輔助腦梗死患者的治療，效果顯著，值得推廣。
목적：관찰중약제제치료뇌경사환자적림상료효，병연구기치료적규범화。방법：대아원2012년3월1일—2014년3월31일소치료적46례뇌경사환자，수궤분위대조조화관찰조각23례，관찰조환자채용중약주사제치료，대조조적환자채용서약침제，료정균위3주，3개월후대기진행치료회방，진이분석대비량조환자적치료효과。결과：치료후량조환자적림상표현균유소개선，여치료전상비，존재명현적차이；관찰조적치료효과현저우우대조조，P＜0.05위차이현저유통계학의의。결론：채용중약주사제보조뇌경사환자적치료，효과현저，치득추엄。
Objective: To observe the clinical curative effects of traditional Chinese medicine preparation on cerebral infarction and study the standardization of the treatment. Methods: 46 cases of cerebral infarction patients in our hospital from 2012 to 2014 were randomly divided into control group and observation group. Each group had 23 cases. Patients in the observation group were treated by traditional Chinese medicine injection and patients in the control group were treated with western medicine injection. The treatment course of the two groups was 3 weeks. After 3 months, return visits were paid to the patients and the curative effects of the two groups were analyzed and compared. Results: After treatment, the clinical manifestations of patients of the two groups were improved. Compared with before treatment, obvious differences existed. The curative effect of the observation group was significantly better than that of the control group and the difference was statistically significant,P<0.05. Conclusion: The effect of traditional Chinese medicine injection on cerebral infarction was significant, so it is worthy of clinical application.
